![](https://www.pdfsearch.io/img/0b6bb920e31aa9949c6027bb973b52c8.jpg) Date: 2013-06-27 13:50:45
| | NOVEN REPORTS POSITIVE PHASE 2 RESULTS FOR MESAFEM™ NON-HORMONAL THERAPY FOR VASOMOTOR SYMPTOMS Miami, FL – July 14, 2009 – Noven Pharmaceuticals, Inc. (NASDAQ: NOVN) today announced positive top-line results from Add to Reading ListSource URL: www.noven.comDownload Document from Source Website File Size: 235,85 KBShare Document on Facebook
|